Salvage therapy for zidovudine-intolerant HIV-infected patients with alternating and intermittent regimens of zidovudine and dideoxycytidine
- 1 May 1990
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 88 (5) , S24-S26
- https://doi.org/10.1016/0002-9343(90)90418-d
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Plasma Viremia in Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989
- Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected PersonsNew England Journal of Medicine, 1989
- Prolonged Zidovudine Therapy in Patients With AIDS and Advanced AIDS-Related ComplexPublished by American Medical Association (AMA) ,1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- Circulating p24 Antigen Levels and Responses to Dideoxycytidine in Human Immunodeficiency Virus (HIV) InfectionsAnnals of Internal Medicine, 1989
- Survival Experience Among Patients With AIDS Receiving ZidovudinePublished by American Medical Association (AMA) ,1988
- PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)The Lancet, 1988
- RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINEThe Lancet, 1987
- Significant Changes in HIV Antigen Level in the Serum of Patients Treated with AzidothymidineNew England Journal of Medicine, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986